Tilvestamab (BGB149) is a humanized antibody targeting AXL with anti-tumor and anti-fibrotic activity, inhibiting Gas6-stimulated AXL activation and tumor progression in 786-0 RCC cells, used in cancer research.
Purity:
>95%
CAS Number:
[2226775-26-2]
Target:
TAM Receptor
* VAT and and shipping costs not included. Errors and price changes excepted